Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccination

This publication has 14 references indexed in Scilit:

• Autoimmune phenomena following SARS-CoV-2 vaccination
  International Immunopharmacology, 2021
• Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series
  Annals of Internal Medicine, 2021
• Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V)
  BMJ Case Reports, 2021
• Reactive arthritis after COVID-19 vaccination
  Human Vaccines & Immunotherapeutics, 2021
• Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination
  Vaccines, 2021
• COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic
  Journal of Scleroderma and Related Disorders, 2020
• Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
  Vaccines, 2020
• Toll‐like Receptor 9 Signaling Is Augmented in Systemic Sclerosis and Elicits Transforming Growth Factor β–Dependent Fibroblast Activation
  Arthritis & Rheumatology, 2016
• A rare polymorphism in the gene for Toll‐like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators
  Arthritis & Rheumatism, 2011
• Regulation of autoreactive B cell responses to endogenous TLR ligands
  Autoimmunity, 2009